alexa Embracing Recent Strategies In Global Regulatory Affairs | 13785
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Pharmaceutical Regulatory Affairs
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Paschal Iwuh
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.012
Abstract
The main function of Regulatory Affairs in the Pharmaceutical industries is to ensure products sent out to the public are ?right the first time?. There is a zero tolerance to this. This means that regulatory affairs units of various companies must present and submit information regarding new products to the government regulatory agencies long before the product is approved and marketed to the public. In a dynamic world, this poses some challenges to the regulatory affairs units in these companies. Therefore, new strategies must be adopted to address these challenges. There are five factors that may be keys to recent strategies in Global Regulatory Affairs. These are New Product Types, Acquisition/In-Licensing, New Regulatory Requirements, Acceleration to time to market and Emerging Markets. In order to meet all these challenges that face the regulatory affairs department, companies must cope with the need for additional resources as well as meet the need for expert knowledge and local experience to face the demands of new regulatory environments and requirements. For example, there is an increasing trend towards outsourcing, which leads to cost-effective and lean processes. Having additional resources at hand for a certain period of time and sourcing specific expertise and local knowledge when needed keeps the regulatory departments agile and flexible. The important thing to such an outsourcing strategy is the selection of the right partner at the right time. Therefore, selection criteria for outsourcing partners very much depend on the nature of the tasks to be transferred but also on the structure and organization of the pharmaceutical companies concerned.
Biography
Paschal Iwuh is a trained engineer, with over 13 years in the biotechnology and pharmaceutical industries. He has held technical and leadership positions in major biotech, bio-pharmaceutical and consulting companies. Currently, he is the Site Validation Manager of GlaxoSmithKline (GSK), Agbara, Nigeria. Due to his passion for innovation and creativity, he is co-founded of The African Network (TAN). TAN fosters entrepreneurship amongst people of African descent. He became the President and CEO of TAN in 2008. As CEO, Paschal is the leader of the organization and responsible for its global operations, more specifically in Africa and USA. Paschal has a Ph.D. in Business Organization & Management from Capella University, Minneapolis, MN; a Master of Science degree in Chemical Engineering from the Technical University of Budapest, Hungary; a Bachelor of Science degree in Petroleum Engineering (first in his class) from the University of Ibadan, Nigeria and a Business Administration Certificate (with Distinction) from University of California, Berkeley.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version